Vicarious Surgical Inc. announced on March 13, 2025, the appointment of Sarah Romano as Chief Financial Officer, effective April 1, 2025.
Ms. Romano will oversee the company's financial strategy, bringing decades of financial leadership experience in capital markets, including successful fundraising and M&A initiatives in the healthcare sector.
Her previous roles include CFO at Entero Therapeutics and Kiora Pharmaceuticals, where she secured over $50 million in funding and spearheaded M&A activities.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.